marcus evans north america conferences

7th Pharmacovigilance, Drug Safety & Risk Management

Integrating a Robust PV Framework which Enables Predictive Drug Safety and Risk Mitigation throughout Product Lifecycle

13-14 Sep 2017
Philadelphia, PA, United States of America

Why You Should Attend

7th Pharmacovigilance, Drug Safety & Risk Management

This two day conference will enable attendees to streamline risk mitigation and improve drug safety by leveraging tools and technologies and interpreting developments in regulatory compliance. The 7thinstallment of Pharmacovigilance, Drug Safety & Risk Management will focus on improving PV strategies to enable predictive drug safety in order to increase patient safety, and decrease drug risk potential.

Develop more proficient and profound pharmacovigilance strategies to utilize throughout product lifecycle. Streamline drug safety and regulatory approval process and increase patient voluntary reporting.

Key Topics

  • Identify trends in pharmacovigilance to establish predictive drug safety methods
  • Examine existing compliance framework to assess potential impacts of forthcoming regulations affecting
  • Incorporate pharmacovigilance throughout product lifecycle, from clinical development to patient care in order to improve drug safety
  • Leverage tools and technology to enhance pharmacovigilance strategy integration
  • Interpret & utilize real world evidence for optimized signal management
  • Previous Attendees Include

    Baxter Healthcare Corporation, Biogen Idec, Eli Lilly, Gilead
    Sciences, Halozyme Therapeutics, Ipsen Biopharmaceuticals,
    Merck, Sanofi, Shire Human Genetic Therapies, Takeda
    Pharmaceuticals USA, Novartis Pharmaceuticals Corporation,
    Cubist Pharmaceuticals, Inc., EMD Serono, Inc., Pfizer, Inc.,
    Johnson and Johnson, Amgen, and many more!

    Why Choose marcus evans?

    marcus evans specialises in the research and development of strategic events for senior business executives. From our international network of 63 offices, marcus evans produces over 1000 event days a year on strategic issues in corporate finance, telecommunications, technology, health, transportation, capital markets, human resources and business improvement.

    Above all, marcus evans provides clients with business information and knowledge which enables them to sustain a valuable competitive advantage and makes a positive contribution to their success.

    Event Sponsors
    Visit website >>
    Visit website >>

    Event Partners

    Practical Insights From

    Anders Lindholm MD, PhD
    Vice President, Head of Drug Safety Inflammation & Immunology
    Celgene Corporation

    Mariette Boerstoel
    Senior Vice President, Head Global Drug Safety

    John Price, MD PhD
    Vice President, Global Pharmacovigilance and Drug Safety
    Alexion Pharmaceuticals, Inc

    Stephen Klincewicz
    Vice President Pharmacovigilance
    Sorrento Therapeutic

    Alexandre Kiazand, M.D.
    Head Safety Science

    Reema Mehta
    Head of Risk Management Center of Excellence
    Pfizer, Inc.

    Ann Strauss
    Associate Vice President CSRM

    Susan Welsh
    Chief Safety Officer
    CSL Behring

    Click Here For Full Agenda

    Voice of Our Customers
    • “Very informative and interesting while stayed focused in PV/Risk Managemnt. I’m very impressed with the knowledge of the speakers”. – Allergan
    • “Diverse, well organized presentations by experienced people.” – AbbVie
    • “I really enjoyed and took lots of information back with me. Had ongoing changes discussed and future topics which made two days very interesting.” – EMD Serono
    • “Great forum for drug safety/PV, epidemiology and regulatory colleagues to collaborate and learn in a very focused forum.” - Gilead Sciences
    Join the Discussion

    Follow on LinkedIn

    Event Contact

    For all enquiries regarding speaking, sponsoring and attending this conference contact:

    Kirill Pokotilov

    NBC Tower, 9th Floor
    455 North Cityfront Plaza Drive
    Chicago, IL 60611

    312-540-3000 Ext: 6313
    Fax: 312-894-6304